Katrine Rasmussen

Katrine Rasmussen is a skilled regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as a Senior Director for Regulatory Affairs in Rare Disease at Novo Nordisk since December 2020, Katrine has held previous roles including Regulatory Principal Specialist and Director of Regulatory Affairs at AFYX Therapeutics. Their background includes significant positions at Ferring Pharmaceuticals as Associate Director in Global Regulatory Affairs, as well as at Genmab where Katrine advanced to Associate Director of Regulatory Affairs. Early career experience includes a Research Scientist role at Novozymes and a Regulatory Affairs Officer position at Alpharma ApS. Katrine holds a degree from Copenhagen Business School.